Predicate |
Object |
contentType |
Letter|Comment |
issn |
0030-9982 |
issueIdentifier |
5 |
pageRange |
1156- |
publicationName |
JPMA. The Journal of the Pakistan Medical Association |
startingPage |
1156 |
bibliographicCitation |
Amer NA, Rashed AB. Comment on Muhammad Bilal, et al. (J Pak Med Assoc. 72, No-5: 839- 842, 2022) Efficacy of rituximab in patients with rheumatoid arthritis. J Pak Med Assoc. 2023 May;73(5):1156. PMID: 37218266. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c762e3504ff763c5bfc223b67d9c4073 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43bcb885fa0627a7170ca0be5d6e32fb |
date |
202305 |
identifier |
https://pubmed.ncbi.nlm.nih.gov/37218266 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5350 https://portal.issn.org/resource/ISSN/0030-9982 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ |
title |
Comment on Muhammad Bilal, et al. (J Pak Med Assoc. 72, No-5: 839- 842, 2022) Efficacy of rituximab in patients with rheumatoid arthritis |
discusses |
http://id.nlm.nih.gov/mesh/M0244307 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D001172Q000188 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D062606 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000069283Q000627 |